Manufacturing


  • White flags bearing Novo Nordisk's logo are seen against a blue sky.
    Image attribution tooltip
    Courtesy of Novo Nordisk
    Image attribution tooltip

    Novo to expand French plant in GLP-1 production push

    The planned $2.3 billion investment follows an earlier $6 billion commitment to expand manufacturing for drugs like its in-demand medicine Wegovy.

    By Nov. 27, 2023
  • Young woman working in lab
    Image attribution tooltip
    LaylaBird via Getty Images
    Image attribution tooltip
    Sponsored by Cognizant

    Data infrastructure excellence changing the shape of biopharma manufacturing

    Biopharma companies capture data across a variety of different fronts and, so this data must be managed effectively in order to unlock business efficiencies and drive improvements.

    Nov. 20, 2023
  • An injector of Eli Lilly's weight loss treatment Zepbound is seen against a neutral background.
    Image attribution tooltip
    Courtesy of Eli Lilly
    Image attribution tooltip

    Lilly plans new $2.5B manufacturing plant as obesity drug demand ramps up

    Following the approval of Zepbound, Lilly is adding capacity to avert shortages and restricted access.

    By Nov. 17, 2023
  • Vaccine vials on a production line in a pharmaceutical factory.
    Image attribution tooltip
    luza studios via Getty Images
    Image attribution tooltip
    Sponsored by Emergent

    3 things manufacturers need to know about the new Annex 1 revision

    As biopharmaceutical organizations around the globe adjust to the new guidelines, Baroni shared insights on three things they need to know about Annex 1.

    Nov. 13, 2023
  • White flags bearing Novo Nordisk's logo are seen against a blue sky.
    Image attribution tooltip
    Courtesy of Novo Nordisk
    Image attribution tooltip
    Obesity drugs

    Novo takes aim at obesity drug shortages with $6B manufacturing plan

    The maker of Wegovy and Ozempic plans to expand production in its home country of Denmark to help meet surging demand for the GLP-1 drugs.

    By Nov. 10, 2023
  • PHCbi appliances.
    Image attribution tooltip
    Permission granted by PHC Corporation of North America
    Image attribution tooltip
    Sponsored by PHC Corporation of North America

    Futureproofing your lab to meet tomorrow’s sustainability standards

    Industry-leading cold storage manufacturers are engineering new solutions that can reliably meet performance benchmarks while consuming far less energy than yesterday’s ULT and laboratory-grade freezers.

    Nov. 6, 2023
  • This image depicts the podcast series cover image for NTT Data's BioPharma Dive series, "Secure Innovation: How Life Sciences and Pharmaceutical Companies Can Safely Seize Opportunity"
    Image attribution tooltip
    Alyssa Sierra/BioPharma Dive
    Image attribution tooltip
    Sponsored by NTT DATA

    [Podcast] Secure Innovation: How Life Sciences and Pharmaceutical Companies Can Safely Seize Opportunity

    This podcast series explores how life sciences companies can bolster their cybersecurity while growing their business.

    Updated Nov. 28, 2023
  • A 3D illustration of cancer cells.
    Image attribution tooltip
    Dr_Microbe via Getty Images
    Image attribution tooltip

    With $56M, a Mayo Clinic-backed startup takes aim at radiopharmaceutical roadblocks

    Nucleus RadioPharma, a contract developer and manufacturer, is expanding at a time when investment is pouring into the radiopharmaceutical drug field.

    By Oct. 17, 2023
  • The logo of German pharmaceuticals and chemicals giant Bayer stands over Bayer corporate offices on September 14, 2016 in Berlin, Germany.
    Image attribution tooltip
    Sean Gallup via Getty Images
    Image attribution tooltip

    Bayer opens California plant to make cell therapies

    The pharma plans for the new Berkeley facility to produce clinical, and potentially commercial, supplies of a Parkinson’s disease cell therapy being tested by its subsidiary BlueRock. 

    By Oct. 10, 2023
  • Woman after chemotherapy visiting doctor in hospital
    Image attribution tooltip
    Permission granted by MMIT
    Image attribution tooltip
    Sponsored by MMIT

    Using real-world data to improve patient access to oncology therapies

    Oncology manufacturers can improve access by using claims, labs, pathway and policy data to address misalignment. 

    By Carolyn Zele, Solution Consulting Advisor, MMIT • Oct. 9, 2023
  • A building framed through tree foliage is seen with a sign that reads "Lilly."
    Image attribution tooltip

    Kris Tripplaar/Sipa/Newscom

    Image attribution tooltip

    Lilly eczema drug turned back by FDA over manufacturing

    The rejection of lebrikizumab is Lilly’s second for an immunology drug this year, following a complete response letter for mirikizumab in April. 

    By Oct. 2, 2023
  • A chemist in the lab working on a chemical experiment
    Image attribution tooltip
    Permission granted by BioPharmaSpec
    Image attribution tooltip
    Sponsored by BioPharmaSpec

    Process-related impurities: Looking beyond the API for safer biotherapeutics

    De-risk your biomanufacturing- an essential mini-guide to detection and quantitation of residuals.

    Oct. 2, 2023
  • A man looks at a glass test tube in a lab, with beakers and additional tubes on a surface in front of him. Overlaid on the image are strands of double-helix DNA and chemistry diagrams.
    Image attribution tooltip
    metamorworks via Getty Images
    Image attribution tooltip

    Novo Nordisk parent backs cell therapy manufacturing facility

    The Novo Nordisk Foundation’s planned manufacturing facility will help both private companies and academic researchers develop new cell therapies.

    By Sept. 21, 2023
  • Abstract blue web of medical icons.
    Image attribution tooltip

    Shutterstock / Hilch

    Image attribution tooltip
    Sponsored by OM1

    Reclaiming registries for integrated evidence generation throughout the product life cycle

    As integrated evidence generation takes center stage for driving evidence-based decision making across the product life cycle, automated registries just might be the linchpin that pulls it all together.

    By Richard Gliklich, MD, CEO, OM1 • Sept. 18, 2023
  • Roche Pharmaceutical Group's office building in Shanghai, China
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    Manufacturing delays under-the-skin Tecentriq shot in US

    Roche says it won’t be able to launch the subcutaneous version of the drug until 2024 as it works with the FDA on manufacturing updates.

    By Sept. 8, 2023
  • People walk past a building in New York City
    Image attribution tooltip
    Spencer Platt via Getty Images
    Image attribution tooltip

    Catalent expands board in deal with activist investor Elliott

    The CDMO is adding four new independent directors to its board, and has set up a committee to review its business and capital allocation priorities.

    By Aug. 29, 2023
  • An illustration of immune system T cells attacking cancer cells.
    Image attribution tooltip
    Meletios Verras via Getty Images
    Image attribution tooltip

    Startup Cellares adds $255M as investors pour cash into cell therapy production

    Bristol Myers Squibb is among those backing the company, which claims the manufacturing capacity at its New Jersey plant can surpass that of conventional CDMO facilities. 

    By Kristin Jensen • Aug. 24, 2023
  • Scientist observing vial
    Image attribution tooltip
    Permission granted by MilliporeSigma
    Image attribution tooltip
    Sponsored by MilliporeSigma

    5 ways experience matters in gene therapy manufacturing

    By partnering with an accomplished CTDMO, gene therapy innovators can benefit from guidance and support.

    Aug. 21, 2023
  • Image attribution tooltip
    Tasos Katopodis via Getty Images
    Image attribution tooltip

    Emergent to lay off around 400 in pivot away from contract manufacturing

    The job cuts will affect “all areas of the company” and, combined with other cost-reduction efforts, lead to annualized savings of over $100 million, Emergent said.

    By Aug. 8, 2023
  • Man in medical lab manufacturing DNA.
    Image attribution tooltip
    Permission granted by Center for Breakthrough Medicines
    Image attribution tooltip
    Sponsored by Center for Breakthrough Medicines

    Cell and gene therapy is coming of age

    Outsourcing in the cell and gene therapy industry is booming and no longer considered just a “trend.”

    July 24, 2023
  • Woman in lab coat and gear analyzing two different pill medicines.
    Image attribution tooltip
    Motortion via Getty Images
    Image attribution tooltip
    Sponsored by Altasciences

    Optimize your drug development timeline with liquid-filled, hard-shell capsules

    With this highly marketable dosage form, scientists can effectively formulate poorly soluble drugs and supplements, while reducing development time and costs.

    July 17, 2023
  • Science lab with table in the middle.
    Image attribution tooltip
    Permission granted by Center for Breakthrough Medicine
    Image attribution tooltip
    Sponsored by Center for Breakthrough Medicines

    Overcoming AAV manufacturing challenges

    Overcome issues with AAV vector scalability and reproducibility. Enable a wider application of gene therapies in a cost-effective and sustainable way.

    July 10, 2023
  • Person holding a vial
    Image attribution tooltip
    Permission granted by Emergent
    Image attribution tooltip
    Sponsored by Emergent

    4 steps for a smooth tech transfer when working with a CDMO

    When developing a new drug product, quality, safety and timing are critical. A CDMO can be a valuable partner to help mitigate risks.

    June 20, 2023
  • A sign for the Food and Drug Administration is seen on July 20, 2020 in Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Ferring, with manufacturing update, takes a step towards first gene therapy sales

    The FDA has cleared Ferring’s planned scale-up process for its bladder cancer treatment Adstiladrin, which the company plans to make available in the U.S. later this year.

    By June 13, 2023
  • A flag with the Novo Nordisk logo.
    Image attribution tooltip
    Novo Nordisk
    Image attribution tooltip

    Novo Nordisk to invest over $2B in drug ingredient production

    The company said the spending will help it manufacture future treatments for chronic diseases, adding to a string of recent plant investments.

    By June 12, 2023